secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2022-10-25T23:59:59+00:00
Accession:  0001171843-22-006726
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology appoints tissue law expert David S. Smith to board
----------------------------------------------------------------------

- David S. Smith, JD, elected to Board as Class III director, term expiring at 2024 annual meeting.
- Smith fills vacancy created by resignation of Christina Jenkins, M.D. in August 2022.
- Smith is a life sciences attorney and authority on legal issues around therapeutic use of human tissue and cells.
- Company granted Smith shares of common stock valued at $5,000 under 2012 Stock Incentive Plan.
- CEO-elect Raymond Vennare praises Smith's understanding of Predictive Oncology's proprietary biorepository.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322006726/0001171843-22-006726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322006726/f8k_102522.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-006726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer